| Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study M Gounder, P Schöffski, RL Jones, M Agulnik, GM Cote, VM Villalobos, ... The Lancet Oncology 21 (11), 1423-1432, 2020 | 293 | 2020 |
| Ivosidenib in isocitrate dehydrogenase 1–mutated advanced glioma IK Mellinghoff, BM Ellingson, M Touat, E Maher, I Macarena, M Holdhoff, ... Journal of clinical oncology 38 (29), 3398, 2020 | 237 | 2020 |
| Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1β/erbB4 signaling Y Kuramochi, GM Cote, X Guo, NK Lebrasseur, L Cui, R Liao, DB Sawyer Journal of Biological Chemistry 279 (49), 51141-51147, 2004 | 234 | 2004 |
| Programmed cell death ligand 1 expression in osteosarcoma JK Shen, GM Cote, E Choy, P Yang, D Harmon, J Schwab, GP Nielsen, ... Cancer immunology research 2 (7), 690-698, 2014 | 201 | 2014 |
| Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes TA Miller, NK LeBrasseur, GM Cote, MP Trucillo, DR Pimentel, Y Ido, ... Biochemical and biophysical research communications 336 (1), 309-315, 2005 | 176 | 2005 |
| Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy E Choy, JE Butrynski, DC Harmon, JA Morgan, S George, AJ Wagner, ... BMC cancer 14 (1), 1-6, 2014 | 172 | 2014 |
| Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; results of a first-in-human phase I trial IK Mellinghoff, M Penas-Prado, KB Peters, HA Burris III, EA Maher, ... Clinical cancer research 27 (16), 4491-4499, 2021 | 171 | 2021 |
| Neuregulin-1α and β isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro GM Cote, TA Miller, NK LeBrasseur, Y Kuramochi, DB Sawyer Experimental cell research 311 (1), 135-146, 2005 | 141 | 2005 |
| Nirogacestat, a γ-secretase inhibitor for desmoid tumors M Gounder, R Ratan, T Alcindor, P Schöffski, WT Van Der Graaf, BA Wilky, ... New England Journal of Medicine 388 (10), 898-912, 2023 | 121 | 2023 |
| ERBB2 inhibition and heart failure GM Cote, DB Sawyer, BA Chabner New England Journal of Medicine 367 (22), 2150-2153, 2012 | 120 | 2012 |
| Clinicopathologic characteristics of poorly differentiated chordoma AR Shih, GM Cote, I Chebib, E Choy, T DeLaney, V Deshpande, ... Modern Pathology 31 (8), 1237-1245, 2018 | 119 | 2018 |
| Contemporary sarcoma diagnosis, genetics, and genomics IM Schaefer, GM Cote, JL Hornick Journal of Clinical Oncology 36 (2), 101-110, 2018 | 115 | 2018 |
| Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle NK Lebrasseur, GM Coté, TA Miller, RA Fielding, DB Sawyer American Journal of Physiology-Cell Physiology 284 (5), C1149-C1155, 2003 | 110 | 2003 |
| Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma Y Feng, J Shen, Y Gao, Y Liao, G Cote, E Choy, I Chebib, H Mankin, ... Oncotarget 6 (13), 11139, 2015 | 108 | 2015 |
| Phase I study of the mutant IDH1 inhibitor ivosidenib: safety and clinical activity in patients with advanced chondrosarcoma WD Tap, VM Villalobos, GM Cote, H Burris, F Janku, O Mir, M Beeram, ... Journal of Clinical Oncology 38 (15), 1693, 2020 | 107 | 2020 |
| Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing … J Powderly, G Cote, K Flaherty, RZ Szmulewitz, A Ribas, J Weber, D Loo, ... Journal for immunotherapy of cancer 3 (2), 1-2, 2015 | 96 | 2015 |
| CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma Y Gao, Y Feng, JK Shen, M Lin, E Choy, GM Cote, DC Harmon, ... Scientific reports 5 (1), 11365, 2015 | 96 | 2015 |
| Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma L Jerby-Arnon, C Neftel, ME Shore, HR Weisman, ND Mathewson, ... Nature medicine 27 (2), 289-300, 2021 | 93 | 2021 |
| Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma GM Cote, EP Hochberg, A Muzikansky, FH Hochberg, J Drappatz, ... Biology of Blood and Marrow Transplantation 18 (1), 76-83, 2012 | 87 | 2012 |
| Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1 E Choy, LE MacConaill, GM Cote, LP Le, JK Shen, GP Nielsen, AJ Iafrate, ... PloS one 9 (7), e101283, 2014 | 85 | 2014 |
